Xtandi 40 mg Capsule

Xtandi 40 mg Capsule contains enzalutamide, a targeted anticancer medicine used for prostate cancer. Each capsule contains 40 mg of enzalutamide and is taken orally as prescribed by a healthcare professional. It works by blocking androgen receptor signaling that can promote prostate cancer growth.

BUY NOW

Category Astellas Pharma Inc

Description

Enzalutamide is an androgen receptor inhibitor that interferes with hormonal signals involved in the growth and survival of prostate cancer cells. Xtandi is used in eligible adult men with prostate cancer, including certain metastatic hormone-sensitive and castration-resistant forms. The medicine is generally continued according to the prescribed oncology treatment plan and may be used alongside androgen deprivation therapy when indicated. Treatment should be initiated and monitored by a qualified healthcare professional.

Technical Specification

Specification	Details
Active Ingredient	Enzalutamide
Strength	40 mg
Dosage Form	Capsule
Route of Administration	Oral
Pack Size	112 Capsules
Manufacturer	Astellas Pharma Inc

Product Also Known As

Xtandi 40 mg Capsule, Enzalutamide 40 mg Capsule, Xtandi Enzalutamide Capsule, Enzalutamide Prostate Cancer Capsule, Androgen Receptor Inhibitor Capsule, Prostate Cancer Treatment Capsule